[
    "{\"step_by_step_thinking\": \"Axitinib is a tyrosine kinase inhibitor that is primarily used in the treatment of renal cell carcinoma and has been studied in other types of cancer. However, according to current medical literature, there is no definitive evidence to suggest that Axitinib prolongs survival in patients with pancreatic cancer.\", \"answer_choice\": \"B. no\"}"
]